Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Epithelial Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00004206
What this trial is testing

Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
University of Leicester
Early research (Phase 1)Looking for participantsNCT05410717
What this trial is testing

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
Stage IV Ovarian CancerTestis Cancer, RefractoryEndometrial Cancer Recurrent+1 more
Second Affiliated Hospital of Guangzhou Medical University 200
Early research (Phase 1)Study completedNCT01248949
What this trial is testing

Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Recurrent Ovarian Tumors
MedImmune LLC 162
Testing effectiveness (Phase 2)Study completedNCT00334893
What this trial is testing

Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)UnknownNCT05819060
What this trial is testing

The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab

Who this might be right for
Recurrent Ovarian Cancer
Fudan University 44
Testing effectiveness (Phase 2)Looking for participantsNCT05512208
What this trial is testing

Avutometinib (VS-6766) Plus Defactinib

Who this might be right for
Endometrioid CancerMucinous Ovarian CancerHigh Grade Serous Ovarian Cancer+2 more
University of Oklahoma 55
Early research (Phase 1)Study completedNCT02028117
What this trial is testing

Phase I / Dose Expansion Study of Enadenotucirev in Ovarian Cancer Patients

Who this might be right for
Recurrent Platinum Resistant Ovarian Cancer
Akamis Bio 38
Testing effectiveness (Phase 2)UnknownNCT06509971
What this trial is testing

QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
West China Second University Hospital 39
Testing effectiveness (Phase 2)Ended earlyNCT00055432
What this trial is testing

Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cancer
Eli Lilly and Company
Early research (Phase 1)Study completedNCT01440998
What this trial is testing

Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Ended earlyNCT00023907
What this trial is testing

Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Large-scale testing (Phase 3)Study completedNCT00382811
What this trial is testing

OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer

Who this might be right for
Fallopian Tube CancerPeritoneal NeoplasmsOvarian Cancer
MEI Pharma, Inc. 142
Early research (Phase 1)Study completedNCT01489371
What this trial is testing

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Ovarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Seromucinous Carcinoma+5 more
Gynecologic Oncology Group 16
Early research (Phase 1)Study completedNCT01131234
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Ended earlyNCT01334047
What this trial is testing

Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer Patients

Who this might be right for
Recurrent Epithelial Ovarian Cancer
Steinar Aamdal 5
Early research (Phase 1)Study completedNCT02903771
What this trial is testing

Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms
Kazia Therapeutics Limited 32
Large-scale testing (Phase 3)Looking for participantsNCT03458221
What this trial is testing

Signal TrAnsduction Pathway Activity Analysis in OVarian cancER

Who this might be right for
Recurrent Ovarian CancerSignal Transduction Pathway DeregulationTherapy-Associated Cancer
Gynaecologisch Oncologisch Centrum Zuid 148
Testing effectiveness (Phase 2)Looking for participantsNCT05704621
What this trial is testing

Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance

Who this might be right for
Ovarian CancerDrug Related Neoplasm/Cancer
Korea University Guro Hospital 124
Not applicableLooking for participantsNCT07667192
What this trial is testing

Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer

Who this might be right for
Recurrent Gynecologic CancerRecurrent Uterine CancerRecurrent Cervical Cancer+5 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 500
Testing effectiveness (Phase 2)Study completedNCT00979992
What this trial is testing

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

Who this might be right for
Ovarian Clear Cell AdenocarcinomaRecurrent Ovarian Carcinoma
National Cancer Institute (NCI) 35
Next Page